LIEBERMAN GERALD M
Insider CIK 1234346 · ENTX Director · FRX Director · TEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 130,149 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-05-28 | 2026-06-01 | 7,242 | — | $0 | 7,242 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2026-01-01 | 2026-01-02 | 33,505 | — | $0 | 33,505 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award | 2026-01-01 | 2026-01-02 | 38,294 | — | $0 | 338,454 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 115,657 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-06-05 | 2025-06-09 | 14,492 | — | $0 | 14,492 | SEC↗ |
| ENTX Entera Bio Ltd. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 23,952 | — | $0 | 28,509 | SEC↗ |
| ENTX Entera Bio Ltd. | M Exercise | 2025-04-01 | 2025-04-03 | 23,952 | $1.00 | $24.0K | 300,160 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2025-01-15 | 2025-01-17 | 28,509 | — | $0 | 28,509 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award | 2025-01-15 | 2025-01-17 | 10,717 | — | $0 | 276,208 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award | 2024-10-02 | 2024-10-04 | 11,269 | — | $0 | 265,491 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award | 2024-08-27 | 2024-08-29 | 27,261 | — | $0 | 254,222 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 106,025 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-06-06 | 2024-06-10 | 9,632 | — | $0 | 9,632 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2024-01-01 | 2024-01-03 | 108,333 | — | $0 | 108,333 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy deriv | 2023-12-22 | 2023-12-27 | 23,952 | $0.13 | $3.1K | 23,952 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2023-12-22 | 2023-12-27 | 23,952 | $0.71 | $17.0K | 226,961 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2023-08-21 | 2023-08-23 | 20,000 | $0.59 | $11.8K | 214,209 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 84,917 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-06-15 | 2023-06-20 | 21,108 | — | $0 | 21,108 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2023-01-02 | 2023-01-04 | 89,041 | — | $0 | 89,041 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-11-14 | 2022-11-15 | 34,000 | $0.57 | $19.4K | 194,209 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-11-14 | 2022-11-15 | 4,000 | $0.56 | $2.2K | 6,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-11-14 | 2022-11-15 | 4,000 | $0.56 | $2.2K | 6,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-11-14 | 2022-11-15 | 4,000 | $0.59 | $2.4K | 6,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-11-14 | 2022-11-15 | 4,000 | $0.56 | $2.2K | 6,200 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-08-04 | 2022-08-08 | 15,810 | — | $0 | 15,810 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-07-21 | 2022-07-25 | 19,491 | $1.68 | $32.7K | 160,209 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 69,107 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-01-18 | 2022-01-24 | 700 | $2.80 | $2.0K | 2,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-01-18 | 2022-01-24 | 700 | $2.81 | $2.0K | 2,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-01-18 | 2022-01-24 | 700 | $2.81 | $2.0K | 2,200 | SEC↗ |
| ENTX Entera Bio Ltd. | P Buy | 2022-01-18 | 2022-01-24 | 700 | $2.78 | $1.9K | 2,200 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2022-01-01 | 2022-01-11 | 35,852 | — | $0 | 35,852 | SEC↗ |
| ENTX Entera Bio Ltd. | A Award deriv | 2022-01-01 | 2022-01-11 | 107,557 | — | $0 | 107,557 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-06-14 | 2021-06-16 | 14,479 | — | $0 | 14,479 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 54,628 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 41,960 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 35,919 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 27,963 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-06-09 | 2020-06-11 | 12,668 | — | $0 | 12,668 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-06-11 | 2019-06-13 | 17,621 | — | $0 | 17,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2019-05-16 | 2019-05-20 | 2,780 | — | $0 | 10,342 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2018-09-03 | 2018-09-05 | 2,162 | — | $0 | 7,562 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-06-05 | 2018-06-07 | 6,041 | — | $0 | 6,041 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 7,815 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 5,909 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 20,000 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 1,527 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 2,406 | — | $0 | 0 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-08-15 | 2013-08-16 | 5,909 | — | $0 | 5,909 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-08-15 | 2013-08-16 | 1,761 | — | $0 | 3,933 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2012-08-23 | 2012-08-27 | 7,815 | — | $0 | 7,815 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2012-08-23 | 2012-08-27 | 2,172 | — | $0 | 2,172 | SEC↗ |